Drug application
DAUNOXOME (DAUNORUBICIN CITRATE)
Drugs@FDA NDA 050704 · GALEN (UK)
Key facts
| Drug name | DAUNOXOME |
|---|---|
| Active ingredients | DAUNORUBICIN CITRATE |
| Application type | NDA |
| Application number | 050704 |
| Company | GALEN (UK) |
| Dosage forms | INJECTABLE, LIPOSOMAL, INJECTION |
| Strength | EQ 2MG BASE/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Apr 8, 1996 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: